Mater Research
Support Us
  • Home
  • About us
    • Mission and vision
    • Strategy
    • History
    • Executives
    • Executive Board
    • Research Advisory Board
    • Organisational structure
    • Partners and collaborators
    • Employment
    • Gender Equity Initiative
    • Media and Communications
  • Our research
    • Research programs and groups
    • Clinical Trials
      • For participants
      • For Industry Sponsors
    • Biobanks
      • David Serisier Respiratory Biobank
      • Mater Inflammatory Bowel Disease (IBD) Biobank
    • Participate in research at Mater
      • Participate in a clinical trial
      • Volunteer Consumer Representatives
      • Submit a Compliment or Complaint
  • Researchers
    • Our researchers
    • For researchers
      • Ethics and Governance
      • Mater Clinical Trials Unit
      • Biobanks | Important information for researchers
      • Mater, TRI and UQ Quick Links
      • Submit a Compliment or Complaint
    • Mater Research award winners
    • Career track fellows
    • Sisters of Mercy Medals
  • Students
    • Current students
      • Student committee
    • Future students
      • Student Research Opportunities
      • Why study at Mater Research
      • Scholarships and Awards
      • Application Process
      • Register your interest for a Student Project
      • Student life
  • News and Events
    • News
    • Events
    • Publications
  • Support Us
  • Home
  • About us
    • Mission and vision
    • Strategy
    • History
    • Executives
    • Executive Board
    • Research Advisory Board
    • Organisational structure
    • Partners and collaborators
    • Employment
    • Gender Equity Initiative
    • Media and Communications
  • Our research
    • Research programs and groups
    • Clinical Trials
      • For participants
      • For Industry Sponsors
    • Biobanks
      • David Serisier Respiratory Biobank
      • Mater Inflammatory Bowel Disease (IBD) Biobank
    • Participate in research at Mater
      • Participate in a clinical trial
      • Volunteer Consumer Representatives
      • Submit a Compliment or Complaint
  • Researchers
    • Our researchers
    • For researchers
      • Ethics and Governance
      • Mater Clinical Trials Unit
      • Biobanks | Important information for researchers
      • Mater, TRI and UQ Quick Links
      • Submit a Compliment or Complaint
    • Mater Research award winners
    • Career track fellows
    • Sisters of Mercy Medals
  • Students
    • Current students
      • Student committee
    • Future students
      • Student Research Opportunities
      • Why study at Mater Research
      • Scholarships and Awards
      • Application Process
      • Register your interest for a Student Project
      • Student life
  • News and Events
    • News
    • Events
    • Publications
  • Support Us
Home   Researchers   Our researchers
A/Prof Sumaira Hasnain

A/Prof Sumaira Hasnain

sumaira.hasnain@mater.uq.edu.au
+61 7 3443 6939
  • LinkedIn
  • ResearchID
  • BioCurrent ResearchGeneral InformationRelated News

    A/Prof Sumaira Hasnain

    • Group Leader - Immunopathology Research

    A/Prof Sumaira Hasnain

    A/Prof Sumaira Hasnain is a National Health and Medical Research Council (NHMRC) Career Development Fellow and Senior Research Fellow at Mater Research, where she heads the Immunopathology Research Group. Sumaira has an interest in chronic inflammatory diseases such as pulmonary fibrosis, inflammatory bowel disease and diabetes as well as infectious diseases.

    Sumaira was the first globally to demonstrate that immunity can modulate protein production in secretory cells in infection and chronic inflammatory diseases. Her long-term vision is to characterise these novel immune factors and manipulate them therapeutically using pre-clinical models of immune-driven pathologies. She holds a patent for targeted immunotherapy of a specific immune factor in both type 1 and type 2 diabetes.

    Sumaira has had a rapid upward trajectory in research, evident by extensive body of high quality publications (over 20 papers) in well recognised scientific journals. She has been awarded around $3 million in competitive funding and has won 17 scientific awards including the Mater Research Strategic Grant for Outstanding Women in 2017. Sumaira is well recognised speaker in the field and has delivered many international conference presentations (including the Gordon Research Conference on Cilia, Mucus & Mucociliary Interactions (USA) & European Association for the Study of Diabetes (UK) in 2017. She currently serves on the Australasian Society for Immunology National Council as the Queensland representative.

    “As a naturally curious person, I have a strong passion for research. I have strategically modelled my laboratory to successfully discover, translate and deliver novel therapies for high burden diseases. I strongly believe that successful leaders are also proactive mentors, and I am proud of successfully establishing the Mater Early Career Researcher Committee program in 2011 and am heavily involved in mentoring of junior scientists“.

    Research Interests

    • Immunology not elsewhere classified - Immunology

    Current research

    • Group Leader - Immunopathology Research
    • Program Member - Chronic and Integrated Care

    Funding

    • 2016 - University of Queensland (Foundation Research Excellence Awards (FREA)) - $95,921.00
      Funded ProjectTargeting Cellular Stress in Autoimmune Diabetes
    • 2015 - National Health and Medical Research Council (Development Grant) - $484,644.00
      Funded ProjectPancreatic targeting of IL-22 therapy for diabetes
    • 2015 - National Health and Medical Research Council (Project Grant) - $222,322.00
      Funded ProjectElucidation of the mechanism of IL-22 mediated suppression of B-cell stress in diabetes
    • 2015 - University of Queensland (Early Career Researcher (ECR)) - $39,960.00
      Funded ProjectUnderstanding Cytokine Regulation of Oxidative and ER stress in Infectious and Inflammatory Disease
    • 2014 - National Health and Medical Research Council (Project Grant) - $822,656.00
      Funded ProjectIL-22 as a Suppressor of Oxidative and ER Stress in ?-Cells and a Treatment for Diabetes
    • 2014 - University of Queensland (Postdoctoral Research Fellowship (PDRF)) - $346,408.97
      Funded ProjectCytokine Modulation of Secretory Cell Function via Oxidative and Endoplasmic Reticulum Stress in Infection and Inflammation
    • 2014 - University of Queensland (UQ Collaboration and Industry Engagement Fund (CIEF)) - $74,779.00
      Funded ProjectPancreatic targeting of IL-22 therapy for diabetes
    • 2012 - National Health and Medical Research Council (Project Grant) - $541,472.10
      Funded ProjectER Stress as a Contributing Factor in Inflammatory Disease

    Contact Us

    07 3163 2555

    Send an online enquiry

    Level 3, Aubigny Place
    Raymond Terrace
    South Brisbane, Qld 4101

    Mater Research

    About us
    Our research
    Research programs
    Clinical trials

    Researchers
    Our researchers
    For researchers
    News and events

    Students
    Current students
    Future students
    Support Us
    Sitemap

    Other Mater Sites

    Corporate Website
    Careers
    Mater Cancer Care Centre
    Mater Education
    Mater Foundation
    Mater Centre for Neurosciences

    Mater Health and Wellness
    Mater Mothers
    Mater Online
    Mater Pathology
    Mater Pharmacy
    Mater SafeQuest

    © Mater Misericordiae Ltd . ACN 096 708 922